BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 8621481)

  • 1. Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen gamma chain C terminus.
    Rooney MM; Parise LV; Lord ST
    J Biol Chem; 1996 Apr; 271(15):8553-5. PubMed ID: 8621481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
    Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
    Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of putative fibrinogen Aalpha-, Bbeta-, and GammaA-chain integrin binding sites in endothelial cell-mediated clot retraction.
    Smith RA; Mosesson MW; Rooney MM; Lord ST; Daniels AU; Gartner TK
    J Biol Chem; 1997 Aug; 272(35):22080-5. PubMed ID: 9268349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The residues AGDV of recombinant gamma chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation.
    Hettasch JM; Bolyard MG; Lord ST
    Thromb Haemost; 1992 Dec; 68(6):701-6. PubMed ID: 1287885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen.
    Podolnikova NP; Yakubenko VP; Volkov GL; Plow EF; Ugarova TP
    J Biol Chem; 2003 Aug; 278(34):32251-8. PubMed ID: 12799374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.
    Jennings LK; White MM; Mandrell TD
    Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.
    Holmbäck K; Danton MJ; Suh TT; Daugherty CC; Degen JL
    EMBO J; 1996 Nov; 15(21):5760-71. PubMed ID: 8918453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation.
    Liu Q; Matsueda G; Brown E; Frojmovic M
    Biochim Biophys Acta; 1997 Dec; 1343(2):316-26. PubMed ID: 9434121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
    Tanoue K; Katagiri Y; Suzuki H
    Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis.
    Jirousková M; Smyth SS; Kudryk B; Coller BS
    Thromb Haemost; 2001 Oct; 86(4):1047-56. PubMed ID: 11686323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
    Kubisz P; Suranova J
    Pathol Biol (Paris); 1975 Apr; 23(4):269-75. PubMed ID: 1097991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction.
    Remijn JA; IJsseldijk MJ; De Groot PG
    J Thromb Haemost; 2003 Oct; 1(10):2245-6. PubMed ID: 14521614
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
    Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
    Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction.
    Gartner TK; Ogilvie ML
    Thromb Res; 1988 Jan; 49(1):43-53. PubMed ID: 3347927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads.
    Liu Q; Rooney MM; Kasirer-Friede A; Brown E; Lord ST; Frojmovic MM
    Biochim Biophys Acta; 1998 Jun; 1385(1):33-42. PubMed ID: 9630497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.